Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708512

Cover Image

PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1708512

Medical Affairs Outsourcing Market, By Services, By Industry, By Geography

PUBLISHED:
PAGES: 172 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF (Single User License)
USD 4500
PDF (Multi User License)
USD 7000
PDF (Enterprise User License)
USD 10000

Add to Cart

Global Medical Affairs Outsourcing Market is estimated to be valued at USD 2.60 Bn in 2025 and is expected to reach USD 5.93 Bn by 2032, growing at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 2.60 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 12.50% 2032 Value Projection: USD 5.93 Bn
Figure. Medical Affairs Outsourcing Market Share (%), By Region 2025
Medical Affairs Outsourcing Market - IMG1

Rising drug development costs and complex regulatory requirements have compelled pharmaceutical and biotech companies to increasingly rely on external expertise and services. Medical affairs outsourcing helps to reduce development expenses and speeds up clinical trials and new product launches. It allows companies to stay focused on core competencies while benefitting from specialized skills and insights of outsourcing partners. Various services offered include medical information, medical monitoring, medical reporting and publication planning, along with regulatory support. Advancements in technology have enabled remote and flexible working models, thus, boosting the scope of outsourced activities. Continued digitalization and growing R&D investment in drug development can drive the medical affairs outsourcing market growth.

Market Dynamics:

Global medical affairs outsourcing market growth is driven by factors like rising drug development costs, stringent regulatory norms, and focus on core competencies by pharmaceutical firms. The average cost of developing a new drug has increased substantially over the past few decades to over US$ 2.6 billion currently. Outsourcing certain functions helps to lower costs substantially. Regulatory requirements have also become more complex globally with greater paperwork and compliance standards. Medical affairs outsourcing allows companies to leverage specialized expertise to navigate regulations efficiently. It also allows companies to focus more on core drug discovery and marketing activities while non-core functions are outsourced. Data security and loss of control over critical processes can hamper the market growth. Technological advancements like artificial intelligence and blockchain offers opportunities by enabling remote services and greater data management capabilities.

Key Features of the Study:

  • This report provides in-depth analysis of the global medical affairs outsourcing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global medical affairs outsourcing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Syneos Health, ICON plc, PRA Health Sciences, The Medical Affairs Company (TMAC), Ashfield Healthcare Communications, Promedica International, Synchrogenix Information Strategies, Anthelio Healthcare Solutions, Pharmaceutical Product Development, LLC. (PPD), and Clinquest Group
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global medical affairs outsourcing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • -Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical affairs outsourcing market

Detailed Segmentation-

  • By Services
    • Medical Writing & Publishing
    • Medical Monitoring
    • Medical Science Liaisons (MSLs)
    • Medical Information
    • Others
  • By Industry
    • Pharmaceutical
    • Biopharmaceutical
    • Medical Devices
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • IQVIA Holdings Inc.
    • Ashfield (part of UDG Healthcare plc)
    • Syneos Health
    • Parexel International Corporation
    • ICON plc
    • PRA Health Sciences
    • Pharmaceutical Product Development (PPD)
    • WuXi AppTec
    • SGS SA
    • Covance Inc. (part of LabCorp)
    • Indegene
    • The Medical Affairs Company (TMAC)
    • Synergy Pharmaceuticals
    • Charles River Laboratories
    • KOLgroups
    • ZS Associates
    • McKinsey & Company (Healthcare Practice)
    • Accenture
Product Code: CMI7084

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Services
    • Market Snapshot, By Industry
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Medical Affairs Outsourcing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Medical Affairs Outsourcing Market, By Services, 2021 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Medical Writing & Publishing
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Monitoring
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Science Liaisons (MSLs)
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Information
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Medical Affairs Outsourcing Market, By Industry, 2021 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Biopharmaceutical
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Medical Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Medical Affairs Outsourcing Market, By Region, 2021 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Services, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Industry, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

8. Competitive Landscape

  • Company Profiles
    • IQVIA Holdings Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Ashfield
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Syneos Health
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Parexel International Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ICON plc
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • PRA Health Sciences
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Pharmaceutical Product Development (PPD)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • WuXi AppTec
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • SGS SA
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Covance Inc. (part of LabCorp)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Indegene
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • The Medical Affairs Company (TMAC)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Synergy Pharmaceuticals
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • KOLgroups
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • ZS Associates
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • McKinsey & Company (Healthcare Practice)
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Accenture
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

9. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

10. Reference and Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!